BioPharm Systems announced that it has launched a new web-based application, which enables sponsors and clinical research organizations that use Oracle’s clinical data management and electronic data capture systems to manage user accounts across multiple environments from a single point of entry. Accel-Account Manager is a simple and easy-to-use clinical account management solution that aides users of Oracle Clinical, Remote Data Capture and Thesaurus Management System in the creation and maintenance of accounts.

BioPharm Systems, Inc. announced that Rudolf Coetzee has been named director of business development for the Europe, Middle East and Africa region. Mr. Coetzee will be responsible for developing new business with life sciences organizations, as well as positioning BioPharm Systems as a leader in providing clinical and pharmacovigilance technology solutions necessary to manage clinical trials efficiently. In addition to having successfully started several companies, Mr. Coetzee most recently worked as a clinical scientist in audiology at the Royal National Throat, Nose and Ear Hospital in London.

BioPharm Systems announced that it has developed additional modules for its Siebel Clinical accelerator ASCEND. First released in June 2009, ASCEND is a pre-configured and enhanced version of Oracle's clinical trial management system (CTMS) Siebel Clinical, designed to significantly reduce implementation costs and timeframes, and includes robust capabilities found on many companies' wish lists. The new modules, available a-la-carte to life sciences companies, increase productivity through enhanced compliance and tracking capabilities: Safety Letter Tracking: Stay in compliance ­ and keep sites fully informed ­ with product safety letters. Create safety letter records for products, and attach copies. Indicate which people at which sites need to receive safety letters and when. Generate lists of recipients for safety letters that automatically remove duplicates. Auto-create safety letter records for sites that meet the safety letter criteria ­ even sites that start late. See whether the appropriate product safety letters have been sent to the appropriate sites. Prevent safety letter records from being regenerated or deleted after they have been sent. Investigational Product Tracking: Know how much investigational product have ­ and where have it at all times. Set up inventory locations. Create transaction records from location to location or from location to site. Record quantity shipped, quantity destroyed, quantity on hold, etc. Generate a report that shows drug lot, inventory accountability, and actuals at locations. Electronic Signature: Use electronic signatures to approve trip reports. When changing a trip report status, confirm that the action is intentional and correct. When approving a trip report, re-enter security credentials.